Share


  

Hi , 


In this week’s newsletter, we explore CRISPR’s role in advancing genetic medicine to AI-powered RNA drug discovery—highlighting how synthetic biology is tackling some of the toughest biological challenges. Additionally, learn how: cultivated meat is making its way to the dinner table, precision agriculture is transforming food systems, and biomanufacturing is scaling up for a more sustainable future. Plus, meet our newest conference speaker from Atomic AI, and don't miss our special Black Friday deal on SynBioBeta 2025 passes!


Warm wishes from the SynBioBeta Team for a great Thanksgiving holiday to all who celebrate. 


We’re excited to welcome Raphael Townshend as a new speaker at SynBioBeta 2025!


As the Founder and CEO of Atomic AI, Raphael is pioneering AI-driven RNA drug discovery. With a PhD from Stanford in Geometric Learning of Biomolecular Structure, his work has been featured in Science, Nature, and Cell, and earned honors like Forbes 30 Under 30. He’s also held key roles at DeepMind and Google.


Hear his groundbreaking insights this May at the San Jose Convention Center!


Reminder: Our Black Friday Sale is live! Save $250 on ANY SynBioBeta 2025 Pass—Conference, Startup, Student, Non-Profit, or Exhibit Hall.


Use code BlackFriday at checkout. Sale ends Friday, November 29, at midnight—don’t miss out!


How Cultivated Meat Carved Out Its Plate in History

Discover how cultivated meat evolved from a futuristic concept to an emerging reality poised to transform our dinner tables.






CRISPR Clinical Trial Targets Sickle Cell at Its Genetic Roots

New hope for sickle cell patients emerges as CRISPR trial eliminates the need for donors and addresses the mutation directly.


AI-Powered Protein Engineering Heightened by Cradle Bio's $73M Series B

With new funding, Cradle Bio's AI platform is set to dramatically speed up protein development, making it more efficient and accessible for scientists

Artificial Protein Design Gets Boost From Revolutionary Method

Custom proteins are no longer a dream, thanks to this groundbreaking AI-powered approach.


Bio Base Europe Pilot Plant Launches 75,000 L Fermenter to Meet Bioeconomy Demands

The €34 million investment milestone bridges the gap to large-scale manufacturing with integrated downstream processing.

Like our Digest?

Please feel free to share with friends,

family, and co-workers!


SynBioBeta, LLC

3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@synbiobeta.com


Sent to: _t.e.s.t_@example.com

Unsubscribe

SynBioBeta, 3559 Mount Diablo Boulevard #2, Lafayette, CA 94549, United States


Email Marketing by ActiveCampaign